Teva bids $57.5M for BioXcel agitation drug in bankruptcy sale
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has placed a stalking horse bid to acquire certain assets from BioXcel ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
